Editor's letter

pg-01-nikki-marmery-jpg

Rumblings of concern about growing risk in the loan market are intensifying into full-blown tremors as the phenomenon of covenant-lite loans reaches new heights. In May, private equity firm Kohlberg Kravis Roberts announced its plans to fund a buyout of First Data Corp with a whopping $16 billion of covenant-lite loans, more than double the previous record of $7 billion in the buyout of Univision Communications.

So-called 'cov-lite' loans, which lack performance-related guarantees, have been characterised as a "timebomb", while top UK fund manager Anthony Bolton said it was a question of "when rather than if" this bubble explodes.

Behind the headline-grabbing news, the numbers are even more disturbing. A study of more than 7,000 syndicated loans over the past 10 years from Fitch Ratings found a sudden drop in covenant protection in 2007. Just 52% of loans in the first quarter of 2007 had any guarantees at all in place - down from 68% in 2006 and 80% in 2004. And investors were already worried before that Q1 dip: in December 2006, more than 50% of investors responding to a Fitch poll thought leveraged loan covenant protection was inadequate - up from just over 40% six months earlier.

Analysts are concerned that with a small handful of private equity firms now powering so much investment banking business, banks are being coerced into providing covenant-lite financing for them. But another less obvious trend is perhaps even more revealing: banks are increasingly parcelling up and selling on these loans: they're not the ones holding the risk any more.

The bottom line for investors has to be: watch out.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here